What medicine should you take after resistance to dasatinib?
After becoming resistant to dasatinib, patients need to undergo examination and adjustment of treatment plan under the guidance of a doctor.
1. Replace other tyrosine kinase inhibitors:
1.Imatinib: This is a commonly used tyrosine kinase inhibitor that has therapeutic effects on chronic myelogenous leukemia and can inhibit the growth of tumor cells in the body.
2.Nilotinib: When resistance to dasatinib occurs, nilotinib is another viable option. It may be more sensitive to certain specific gene mutations (such as F317L/V/I/C, V299L, T315A, etc.).
3.Bosutinib: This is also an effective tyrosine kinase inhibitor and is suitable for the treatment of dasatinib resistance.
2. Combined medication:
If monotherapy is ineffective, other drugs, such as axitinib, sunitinib, etc., can be considered to enhance the therapeutic effect. However, combined medication needs to be carried out under the guidance of a doctor to avoid drug interactions and adverse reactions.
3. Considerations for ponatinib:
Ponatinib is a multi-target kinase inhibitor particularly suitable for the treatment of drug-resistant chronic myelogenous leukemia. It has a special inhibitory effect on T315I mutations, etc. Therefore, ponatinib can be used as an important treatment option after resistance to dasatinib.
4. Genetic testing and individualized treatment:
Before switching medications, it is recommended that patients undergo genetic testing to determine specific gene mutations. This helps doctors choose the most appropriate drugs for patients and achieve personalized treatment. For example, according to the results of genetic testing, for the occurrence of Patients with E255KN, Y253H, F359V/C/I gene mutations may still continue to use dasatinib; while for other specific gene mutations, they may need to switch to drugs such as nilotinib, bosutinib or ponatinib.
In addition to drug treatment, patients also need to pay attention to getting more rest in daily life, avoiding overexertion, and paying attention to a light and digestible diet. These lifestyle adjustments can help improve the patient's overall health and improve the effectiveness of treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)